Our progress developing ABS-201 for androgenetic alopecia is ahead of plan as we expect to initiate a phase 1/2a trial in ...
Vehicle systems manufacturer Commercial Vehicle Group (NASDAQ:CVGI) fell short of the markets revenue expectations in Q3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback